Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

PROC

Procaps (PROC)

Procaps Group SA
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PROC
일자시간출처헤드라인심볼기업
2024/05/2105:05Business WireProcaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-FNASDAQ:PROCProcaps Group SA
2024/05/1505:10Business WireProcaps Group Delays Filing of Annual Report on Form 20-FNASDAQ:PROCProcaps Group SA
2024/05/0205:10Business WireProcaps Group Delays Filing of Annual Report on Form 20-FNASDAQ:PROCProcaps Group SA
2024/03/0422:00Business WireProcaps Announces Formation of Strategic Committee to Explore Value Creation AlternativesNASDAQ:PROCProcaps Group SA
2024/02/0522:50Business WireProcaps Issues Shareholder Letter from New CEONASDAQ:PROCProcaps Group SA
2024/01/1622:50Business WireProcaps Group – Notice to ShareholdersNASDAQ:PROCProcaps Group SA
2023/12/2707:40Business WireProcaps Group Reports Third Quarter 2023 ResultsNASDAQ:PROCProcaps Group SA
2023/12/2208:45Business WireStatement from the Board of Directors of Procaps GroupNASDAQ:PROCProcaps Group SA
2023/11/3009:54PR Newswire (US)Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin AmericaNASDAQ:PROCProcaps Group SA
2023/11/3007:42Business WireProcaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin AmericaNASDAQ:PROCProcaps Group SA
2023/11/2222:30Business WireProcaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024NASDAQ:PROCProcaps Group SA
2023/11/1507:25Business WireProcaps Group Update on Third Quarter ResultsNASDAQ:PROCProcaps Group SA
2023/11/1101:37Business WireProcaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023NASDAQ:PROCProcaps Group SA
2023/10/3021:30Business WireProcaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in ColombiaNASDAQ:PROCProcaps Group SA
2023/10/2406:01Business WireProcaps Appoints Sandra Sánchez y Oldenhage to Board of DirectorsNASDAQ:PROCProcaps Group SA
2023/10/1621:31Business WireProcaps Group to Participate at CPHI Barcelona 2023NASDAQ:PROCProcaps Group SA
2023/10/0221:00Business WireProcaps Group to Host Webinar on Colombian Pharma MarketNASDAQ:PROCProcaps Group SA
2023/09/1521:20Business WireProcaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in OctoberNASDAQ:PROCProcaps Group SA
2023/09/0721:30Business WireProcaps Group Announces the Expansion of its Oncology PortfolioNASDAQ:PROCProcaps Group SA
2023/09/0521:25Business WireProcaps Group Reports Second Quarter 2023 ResultsNASDAQ:PROCProcaps Group SA
2023/09/0107:35Business WireProcaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on TuesdayNASDAQ:PROCProcaps Group SA
2023/08/1621:31Business WireProcaps Group Publishes White Paper on Innovative Gummy TechnologyNASDAQ:PROCProcaps Group SA
2023/06/0608:45GlobeNewswire Inc.Procaps Group Reports First Quarter 2023 ResultsNASDAQ:PROCProcaps Group SA
2023/05/1306:30Business WireProcaps Group Reports Fourth Quarter and Full Year 2022 ResultsNASDAQ:PROCProcaps Group SA
2023/05/0121:17GlobeNewswire Inc.Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F FilingNASDAQ:PROCProcaps Group SA
2023/02/1406:36GlobeNewswire Inc.Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 GuidanceNASDAQ:PROCProcaps Group SA
2023/01/2006:32GlobeNewswire Inc.Procaps Announces Key Changes to the Board of DirectorsNASDAQ:PROCProcaps Group SA
2023/01/0406:12GlobeNewswire Inc.Procaps Group Announces Termination of Acquisition Agreement with Grupo SomarNASDAQ:PROCProcaps Group SA
2022/12/2922:00GlobeNewswire Inc.Procaps to Present at 2023 Annual J.P. Morgan Healthcare ConferenceNASDAQ:PROCProcaps Group SA
2022/12/2306:02GlobeNewswire Inc.Update on Proposed Acquisition of Grupo SomarNASDAQ:PROCProcaps Group SA
 검색 관련기사 보기:NASDAQ:PROC